The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Modern insulin pumps are self-contained devices that attach ... a second chip that is likely responsible for the wireless communications, three captive LR44 button cells, and hardly a passive ...

a device that administers insulin automatically at regular intervals in lieu of multiple daily injections. The weakness in these pumps is that they rely on radio frequency, or RF, for wireless ...

In 2011 Medtronic, a major manufacturer of insulin pumps. was told by security researchers that their wireless link was insecure. Future devices closed that security hole, but the existing devices ...

One of the significant advancements in diabetes management is the use of insulin pump therapy, which provides a continuous supply of insulin to help maintain stable blood glucose levels.

Closed loop insulin pump therapy lowers the risk for hypoglycemic coma but increases diabetic ketoacidosis risk among patients with T1D.